Cargando…
Parkinson’s disease-linked Parkin mutations impair glutamatergic signaling in hippocampal neurons
BACKGROUND: Parkinson’s disease (PD)-associated E3 ubiquitin ligase Parkin is enriched at glutamatergic synapses, where it ubiquitinates multiple substrates, suggesting that its mutation/loss-of-function could contribute to the etiology of PD by disrupting excitatory neurotransmission. Here, we eval...
Autores principales: | Zhu, Mei, Cortese, Giuseppe P., Waites, Clarissa L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6130078/ https://www.ncbi.nlm.nih.gov/pubmed/30200940 http://dx.doi.org/10.1186/s12915-018-0567-7 |
Ejemplares similares
-
Impaired anandamide/palmitoylethanolamide signaling in hippocampal glutamatergic neurons alters synaptic plasticity, learning, and emotional responses
por: Zimmermann, Tina, et al.
Publicado: (2018) -
Linking F-box protein 7 and parkin to neuronal degeneration in Parkinson’s disease (PD)
por: Zhou, Zhi Dong, et al.
Publicado: (2016) -
Impaired 2-AG Signaling in Hippocampal Glutamatergic Neurons: Aggravation of Anxiety-Like Behavior and Unaltered Seizure Susceptibility
por: Guggenhuber, Stephan, et al.
Publicado: (2015) -
Mitophagy and Parkinson's disease: The PINK1–parkin link()
por: Deas, Emma, et al.
Publicado: (2011) -
Parkin as a Molecular Bridge Linking Alzheimer’s and Parkinson’s Diseases?
por: Checler, Frédéric, et al.
Publicado: (2022)